European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide - The Manila Times
⚠️ Не удалось извлечь полный текст. Показано краткое содержание из RSS.
🧭 Извлечение: failed · http_403
· confidence 0%
· диагностика
Low confidence: HTTP extraction failure (http_403).
Low confidence: HTTP extraction failure (http_403).
Полный текст не извлёкся (failed). Краткое содержание:
European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide The Manila Times